BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3981859)

  • 21. [Calcium antagonists in the treatment of arterial hypertension. Attempt at a differential therapy].
    Kiowski W
    Fortschr Med; 1984 Jul; 102(27-28):721-4. PubMed ID: 6479815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
    Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of calcium antagonists in the treatment of essential hypertension.
    Klein W; Brandt D; Vrecko K; Härringer M
    Circ Res; 1983 Feb; 52(2 Pt 2):I174-81. PubMed ID: 6831651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The long-term management of hypertension with verapamil.
    Lewis GR
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():107-12. PubMed ID: 6811175
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of corinfar on hemodynamics in ischemic heart disease].
    Gol'dberg GA; Ermakova EN; Shakhshneĭder NM
    Ter Arkh; 1986; 58(5):87-90. PubMed ID: 3526617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Heart rate variability in patients with hypertension and type 2 diabetes treated with long acting calcium antagonists].
    Lopatin IuM; Kirakozov DA; Statsenko ME
    Kardiologiia; 2003; 43(5):33-6. PubMed ID: 12891237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Calcium antagonists in the treatment of nephrogenic hypertension].
    Tareeva IE; Kutyrina IM; Galstian GM; Rogov VA
    Klin Med (Mosk); 1990 Aug; 68(8):52-6. PubMed ID: 2084371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of the effect of short-term treatment with nifedipine and verapamil on blood pressure, plasma atrial natriuretic peptide (ANP) and cyclic guanosine monophosphate (cGMP) in patients with primary arterial hypertension I degree according to WHO].
    Widecka K; Marzecka J; Goździk J; Gruszczyńska M; Ciechanowski K; Czekalski S
    Pol Tyg Lek; 1994 Mar 7-14; 49(10-11):228-30. PubMed ID: 7862584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The hemodynamics of calcium-channel antagonists in hypertension: vascular and myocardial responses.
    Cody RJ
    Circulation; 1987 Jan; 75(1 Pt 2):I175-9. PubMed ID: 3791618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of calcium entry blockers in hypertensive emergencies.
    Bauer JH; Reams GP
    Circulation; 1987 Jun; 75(6 Pt 2):V174-80. PubMed ID: 3552314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dynamic behavior of arterial pressure during exertion. Effects of treatment with 2 different calcium blockers: nifedipine and verapamil].
    González Juanatey JR; Pose Reino A; Amaro Cendón A; Gil de la Peña M
    Med Clin (Barc); 1988 Apr; 90(16):651-5. PubMed ID: 3294533
    [No Abstract]   [Full Text] [Related]  

  • 32. [The clinical efficacy of the new delayed-action calcium antagonist Cordipin-Retard].
    Hapon LI; Abaturova OV; Vershynina AM; Kremn'ova LV; Osokin SB; Sobolevs'kyĭ EV; Alfimova TV
    Lik Sprava; 1993 Sep; (9):57-60. PubMed ID: 8085350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium antagonists, firstline partners for betablockers in hypertension.
    Bühler FR
    Z Kardiol; 1984; 73 Suppl 2():95-9. PubMed ID: 6152093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of calcium antagonists on cerebral and systemic hemodynamics in patients with ischemic disorders of cerebrovascular circulation].
    Ishchenko MM; Lobas VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(9):52-6. PubMed ID: 2692360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of corinfar and finoptin on lipid peroxidation].
    Zhuravlev AK; Murashko VV; Kamchatnov PR
    Klin Med (Mosk); 1988 Apr; 66(4):35-7. PubMed ID: 3398447
    [No Abstract]   [Full Text] [Related]  

  • 36. [Are all calcium antagonists alike?].
    Bertel O
    Schweiz Rundsch Med Prax; 1992 Feb; 81(7):164-7. PubMed ID: 1535950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Calcium antagonists in the treatment of arterial hypertension].
    Chlewicka I; Wasowska T
    Pol Tyg Lek; 1982 Nov; 37(44):1327-9. PubMed ID: 6761674
    [No Abstract]   [Full Text] [Related]  

  • 38. [Evaluation of hypotensive and antiischemic effects of a combination of dihydropyridine and non-dihydropyridine calcium antagonists in patients suffering from coronary artery disease with arterial hypertension].
    Iskendeerov BG; Burmistrova LF; Berenshteĭn NV; Abramova GN; Lokhina TV; Shibaeva TM
    Klin Med (Mosk); 2006; 84(11):52-6. PubMed ID: 17243612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hemodynamic evaluation of the action of calcium antagonists].
    Vincenzi M; Allegri P; Barbieri E; Cappelletti F; Carrozza A; De Lio U; Maiolino P; Morlino T; Ometto R
    Boll Soc Ital Cardiol; 1978; (1 Suppl):79-97. PubMed ID: 757682
    [No Abstract]   [Full Text] [Related]  

  • 40. [The efficacy of the long-term therapy of patients with stable stenocardia using korinfar and finoptin].
    Voronkov LG; Sharaeva ML
    Vrach Delo; 1989 Jul; (7):67-9. PubMed ID: 2800507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.